Additional information
| Dose | 4 doses |
|---|---|
| Strength | 0.25mg 1.5ml PFP, 0.5mg 1.5ml PFP, 1mg 3ml PFP, 1.7mg 3ml PFP, 2.4mg 3ml PFP |
Orders placed after 2pm on Friday 22nd May will be dispatched on Tuesday 26th May due to the Bank Holiday.
PharmaBee provides Wegovy (semaglutide 2.4mg) for eligible adults as part of a clinically supervised weight management programme. All prescriptions are reviewed by our team following a structured online consultation. If appropriate, your medication is dispensed from our UK pharmacy and delivered discreetly.
Wegovy is a once-weekly prescription injection used to support weight management. In the STEP clinical trial programme, participants taking Wegovy 2.4mg achieved average weight reductions of around 15% of starting body weight over approximately 68 weeks.
| Dose | 4 doses |
|---|---|
| Strength | 0.25mg 1.5ml PFP, 0.5mg 1.5ml PFP, 1mg 3ml PFP, 1.7mg 3ml PFP, 2.4mg 3ml PFP |
What Is Wegovy?
Wegovy contains semaglutide 2.4mg. It is a once-weekly prescription injection. Semaglutide is a GLP-1 receptor agonist — GLP-1 is a naturally occurring hormone involved in appetite control and blood sugar regulation.
By activating GLP-1 receptors, Wegovy reduces appetite, increases feelings of fullness, slows stomach emptying, and helps reduce overall calorie intake. Wegovy is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition. It must be used alongside dietary and lifestyle measures.
How Is Wegovy Taken?
Wegovy is supplied in a pre-filled pen.
Treatment starts at 0.25mg weekly and increases gradually over 16 weeks to 2.4mg. Gradual dose escalation helps manage side effects.
Who Is Wegovy Suitable For?
Wegovy may be suitable for adults who meet BMI criteria, have struggled with sustained weight loss, are willing to continue healthy lifestyle changes, and have no contraindications. It may not be appropriate for individuals with a history of medullary thyroid cancer, MEN2, pancreatitis, pregnancy/breastfeeding, or type 1 diabetes.
Wegovy vs Ozempic
Ozempic contains semaglutide but is licensed for type 2 diabetes at lower doses. Wegovy contains a higher maintenance dose (2.4mg) and is licensed specifically for weight management. They are not interchangeable without medical supervision.
What Happens If I Stop Wegovy?
Wegovy supports appetite control while in use. If treatment stops and lifestyle changes are not maintained, appetite may increase and weight regain may occur. Weight management is typically a long-term process.
How effective is Wegovy?
In the STEP clinical trial, participants achieved average weight reductions of around 15% of starting body weight over approximately 68 weeks. These results were achieved in structured trial settings — individual results vary.
How is Wegovy different from Ozempic?
Ozempic contains semaglutide but is licensed for type 2 diabetes at lower doses. Wegovy is licensed specifically for weight management at a higher maintenance dose (2.4mg). They should not be used interchangeably without medical supervision.
How long will I need to take it?
Weight management treatment is often long term. Many patients remain on treatment to help maintain weight reduction, subject to regular clinical review. Stopping treatment without maintaining lifestyle changes may lead to weight regain.
How to request Wegovy from PharmaBee?
Complete our secure online consultation, reviewed by our team. If appropriate, prescription is issued, dispensed from our UK pharmacy, and delivered discreetly.
Common Side Effects
Common side effects include:
These are usually temporary and improve with time.
More Serious Side Effects
More serious but rare risks include:
Seek medical advice if you develop severe abdominal pain. Always read the Patient Information Leaflet before starting treatment.
Medicine Interactions
Because Wegovy slows stomach emptying, it may affect absorption of some oral medicines. You must disclose all prescription medicines, over-the-counter medicines, herbal products, supplements, and other weight loss treatments to ensure safe prescribing.
Copyright © 2026 Mulla Pharm Limited, All Rights Reserved. Company Registration No: 07821735 Website by Arise Digital